CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical's net profit for the first 9 months was approximately RMB 2.601 billion, a year-on-year decrease of 10.28%
China Resources Pharmaceutical (03320) announced the results of China Resources Sanjiu for the first 9 months of 2026, with total operating revenue of approximately RMB 21.41 billion, a year-on-year decrease of 2.62%; net profit of approximately RMB 2.601 billion, a year-on-year decrease of 10.28%.
CHINARES PHARMA (03320) announced the results of China Resources Sanjiu Medical & Pharmaceutical for the first 9 months of 2026, with total operating revenue of approximately RMB 21.41 billion, a year-on-year decrease of 2.62%; net profit of approximately RMB 2.601 billion, a year-on-year decrease of 10.28%.
Related Articles
GOLDWAY EDU (08160): Hui Ka Fai Resigns as Non-Executive Director
YESASIA HLDGS (02209) Q3 operating profit at US$10 million, up 56.3% year-on-year
Zijin Mining Group (02899): Zhang Yan ceases to serve as the company's joint company secretary (Hong Kong)
GOLDWAY EDU (08160): Hui Ka Fai Resigns as Non-Executive Director
YESASIA HLDGS (02209) Q3 operating profit at US$10 million, up 56.3% year-on-year
Zijin Mining Group (02899): Zhang Yan ceases to serve as the company's joint company secretary (Hong Kong)
